Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study.
Roberto CaporaliFrancesco UrsiniPaola CiprianiVasiliki LiakouliFrancesco CarubbiOnorina BerardicurtiGiovambattista De SarroRoberto GiacomelliPublished in: PloS one (2017)
Our study supports the hypothesis of a significant short-term risk of T2D in RA patients and of a close associations between uncontrolled disease activity and glucose metabolism derangement. Further multicentre, randomised-controlled studies are surely needed in order to elucidate these findings and to better ascertain the possible contribution of different therapeutic regimens to reduce this risk.
Keyphrases
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- ankylosing spondylitis
- rheumatoid arthritis patients
- end stage renal disease
- type diabetes
- study protocol
- ejection fraction
- juvenile idiopathic arthritis
- newly diagnosed
- clinical trial
- chronic kidney disease
- prognostic factors
- interstitial lung disease
- randomized controlled trial
- glycemic control
- systemic sclerosis
- skeletal muscle